The antioxidant supplementation of N-acetyl cysteine and vitamin E mimics the NRF2-HMOX-1 action, leading to the BACH1 stabilization and glycolysis induction in KRAS-mutant lung cancer. Here, NFE2L2 is linked to lung cancer.